Search hospitals > Ohio > Cincinnati
Novartis Investigative Site
Claim this profileCincinnati, Ohio 45219
Global Leader in High Blood Pressure
Global Leader in Heart Failure
Conducts research for Pulmonary Hypertension
Conducts research for Pulmonary Arterial Hypertension
Conducts research for Cardiovascular Disease
199 reported clinical trials
17 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Cincinnati, Ohio. This center is recognized for care of High Blood Pressure, Heart Failure, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease and other specialties. Novartis Investigative Site is involved with conducting 199 clinical trials across 194 conditions. There are 17 research doctors associated with this hospital, such as Alexander Starodub, MD, Gina G. Chung, Joseph Choo, MD, and Geoffrey Answini, MD.Top PIs
Alexander Starodub, MDThe Christ Hospital2 years of reported clinical research
Studies Solid Tumors
Studies Tumors
17 reported clinical trials
26 drugs studied
Gina G. ChungThe Christ Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Lymphoma
10 reported clinical trials
32 drugs studied
Joseph Choo, MDThe Christ Hospital6 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Heart Failure
9 reported clinical trials
14 drugs studied
Geoffrey Answini, MDThe Christ Hospital6 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Aortic Aneurysm
8 reported clinical trials
10 drugs studied
Clinical Trials running at Novartis Investigative Site
Pulmonary Arterial Hypertension
High Blood Pressure
Pulmonary Hypertension
Heart Failure
Atrial Fibrillation
Mitral Valve Regurgitation
Hypertrophic Cardiomyopathy
Non-Small Cell Lung Cancer
Coronavirus
Cardiovascular Disease
Sotatercept
for Pulmonary Arterial Hypertension
This trial is testing sotatercept, a medication for high blood pressure in the lungs, in adults with PAH who have completed earlier studies. It aims to see if the medication is safe and effective over a long period. Sotatercept helps lung blood vessels function better, reducing lung pressure. Sotatercept has shown promising results in earlier studies for reducing lung pressure and improving exercise tolerance in patients with pulmonary arterial hypertension (PAH).
Recruiting2 awards Phase 39 criteria
Sotatercept
for Pulmonary Arterial Hypertension
This trial is testing sotatercept, a new medication, to see if it can help people with a specific type of high blood pressure in the lungs (PAH) when added to their usual treatment. The study focuses on patients who are newly diagnosed and at higher risk of their condition worsening. Sotatercept aims to reduce the pressure in the lung's blood vessels, potentially slowing down disease progression. Sotatercept has shown significant reduction in pulmonary vascular resistance and maintained clinical efficacy in previous studies.
Recruiting1 award Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Cincinnati, Ohio. This center is recognized for care of High Blood Pressure, Heart Failure, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease and other specialties. Novartis Investigative Site is involved with conducting 199 clinical trials across 194 conditions. There are 17 research doctors associated with this hospital, such as Alexander Starodub, MD, Gina G. Chung, Joseph Choo, MD, and Geoffrey Answini, MD.